Astrotech (NASDAQ:ASTC) Raised to “Sell” at Wall Street Zen

Astrotech (NASDAQ:ASTC) was upgraded by research analysts at Wall Street Zen from a “strong sell” rating to a “sell” rating in a report issued on Saturday.

Separately, Weiss Ratings raised shares of Astrotech from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Wednesday, May 27th. One investment analyst has rated the stock with a Sell rating, According to MarketBeat, the company presently has an average rating of “Sell”.

Astrotech Price Performance

Shares of NASDAQ ASTC opened at $6.54 on Friday. The firm’s 50-day simple moving average is $15.14 and its 200 day simple moving average is $7.31. The company has a market cap of $11.77 million, a price-to-earnings ratio of -0.78 and a beta of 4.87. Astrotech has a 12-month low of $1.91 and a 12-month high of $68.85.

Astrotech (NASDAQ:ASTC) last issued its quarterly earnings data on Wednesday, May 13th. The aerospace company reported ($2.25) EPS for the quarter. Astrotech had a negative return on equity of 81.85% and a negative net margin of 1,397.82%.The company had revenue of $0.34 million for the quarter.

Hedge Funds Weigh In On Astrotech

Several hedge funds have recently added to or reduced their stakes in the company. Susquehanna International Group LLP acquired a new stake in Astrotech in the third quarter worth about $66,000. DRW Securities LLC raised its holdings in Astrotech by 168.5% during the 4th quarter. DRW Securities LLC now owns 31,464 shares of the aerospace company’s stock worth $109,000 after purchasing an additional 19,747 shares during the last quarter. Finally, J. Safra Sarasin Holding AG acquired a new position in Astrotech during the 1st quarter valued at about $140,000. Institutional investors own 24.35% of the company’s stock.

About Astrotech

Astrotech Corp. (NASDAQ: ASTC) is a technology commercialization company headquartered near Austin, Texas. The firm sources early-stage innovations from government and university research programs—most notably from NASA—and advances them toward commercial readiness. Astrotech’s core mission is to bridge the gap between federally funded R&D and industrial applications across the life sciences and renewable energy sectors.

In its life sciences division, Astrotech has focused on mass spectrometry-based analytical instruments and diagnostic platforms.